Male breast cancer is a rare disease representing < 1% of all breast carcinomas diagnosed in the United States each year. In 2019, an estimated 2,670 new cases of breast cancer were expected to be ...

ASCO has established a process for endorsing other organizations’ clinical practice guidelines. This article summarizes the results of that process and presents the practice recommendations from the ...

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer The search strategy identified 257 ...

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial A total of 121 patients ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

•Cancer cachexia is a highly morbid condition that negatively affects quality of life, reduces tolerance to anticancer therapy, and confers poor survival. Despite this, there is no current US Food and ...

Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer with an extremely uneven geographic global distribution. Although NPC is fairly uncommon in many jurisdictions, it remains a significant ...

This guideline consolidates all previous updates and reflects the body of evidence informing this guideline topic. Ten new RCTs were identified in the latest search of the literature to date.

Of the 117 patients enrolled, 116 completed chemotherapy, with the median age of 32 years: 50% men, 98% stage II, 86% Memorial Sloan Kettering–defined disease bulk, 27% traditional bulk (> 10 cm), 52% ...

Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study ...

CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group A total of 191 patients (modified ...

Cancer Care Ontario (CCO; now a division of Ontario Health [OH]) and ASCO published a joint guideline in 2017 on the use of adjuvant bisphosphonates and other bone-modifying agents (BMAs) in breast ...